The endocannabinoid system and pain.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  CNS and Neurological Disorders - Drug Targets

• Publication date

  2009-11-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/187152709789824660PMID 19839937PMCID PMC2834283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent Advances in the Pharmacological Management of Pain

  2012cited by this paper
• cDNA cloning and characterization of human and mouse Ca(2+)-independent phosphatidylethanolamine N-acyltransferases.

  2009cited by this paper
• Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo.

  2009cited by this paper
• The therapeutic potential of novel cannabinoid receptors.

  2009cited by this paper
• Inhibition of human recombinant T‐type calcium channels by the endocannabinoid N‐arachidonoyl dopamine

  2009cited by this paper
• The endocannabinoid system is modulated in response to spinal cord injury in rats.

  2009influential reference
• The role of the endogenous cannabinoid system in peripheral analgesia.

  2009cited by this paper
• Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase

  2009cited by this paper
• Biology of endocannabinoid synthesis system.

  2009cited by this paper
• Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.

  2009cited by this paper
• The antinociceptive interaction of anandamide and adenosine at the spinal level.

  2009cited by this paper
• The Role of the Endogenous Cannabinoid System in Peripheral Analgesia

  2009cited by this paper
• Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.

  2008cited by this paper
• Endocannabinoids: synthesis and degradation.

  2008influential reference
• Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

  2008cited by this paper
• Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.

  2008cited by this paper
• A Decrease in Anandamide Signaling Contributes to the Maintenance of Cutaneous Mechanical Hyperalgesia in a Model of Bone Cancer Pain

  2008cited by this paper
• The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

  2008cited by this paper
• Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.

  2008cited by this paper
• AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: role for cannabinoid receptors.

  2008cited by this paper
• Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

  2008cited by this paper
• Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.

  2008cited by this paper
• Modulation of the anti‐nociceptive effects of 2‐arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model

  2008influential reference
• Brain TRPV1: a depressing TR(i)P down memory lane?

  2008cited by this paper
• Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).

  2008cited by this paper
• Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non‐cannabinoid receptor‐mediated mechanisms

  2008cited by this paper
• Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

  2008cited by this paper
• A physiological role for endocannabinoid‐derived products of cyclooxygenase‐2‐mediated oxidative metabolism

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008influential reference
• Inhibition of fatty acid amide hydrolase produces PPAR‐α‐mediated analgesia in a rat model of inflammatory pain

  2008influential reference
• Prostaglandin E2 glycerol ester, an endogenous COX‐2 metabolite of 2‐arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Localization of N‐acyl phosphatidylethanolamine phospholipase D (NAPE‐PLD) expression in mouse brain: A new perspective on N‐acylethanolamines as neural signaling molecules

  2008cited by this paper
• Multiple pathways involved in the biosynthesis of anandamide.

  2008cited by this paper
• A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.

  2008cited by this paper
• A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis

  2008cited by this paper
• Faculty Opinions recommendation of Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity.

  2008cited by this paper
• Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.

  2008cited by this paper
• Cannabinoid activation of PPARα; a novel neuroprotective mechanism

  2007cited by this paper
• The orphan receptor GPR55 is a novel cannabinoid receptor

  2007cited by this paper
• Analgesic actions of N‐arachidonoyl‐serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors

  2007influential reference
• Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

  2007cited by this paper
• Cannabinoids and pain.

  2007cited by this paper
• Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.

  2007cited by this paper
• The antinociceptive effects of intraplantar injections of 2‐arachidonoyl glycerol are mediated by cannabinoid CB2 receptors

  2007cited by this paper
• Novel inhibitors of fatty acid amide hydrolase.

  2007cited by this paper
• The complications of promiscuity: endocannabinoid action and metabolism

  2007cited by this paper
• ACTIONS OF THE ENDOCANNABINOID TRANSPORT INHIBITOR AM404 IN NEUROPATHIC AND INFLAMMATORY PAIN MODELS

  2007cited by this paper
• Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats.

  2007influential reference
• The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3′-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice

  2007cited by this paper
• The inhibition of monoacylglycerol lipase by URB602 showed an anti‐inflammatory and anti‐nociceptive effect in a murine model of acute inflammation

  2007cited by this paper
• Biosynthetic Pathways of the Endocannabinoid Anandamide

  2007cited by this paper
• Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain

  2007cited by this paper
• The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

  2007cited by this paper
• Critical enzymes involved in endocannabinoid metabolism.

  2007cited by this paper
• New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain.

  2007influential reference
• Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

  2007cited by this paper
• Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.

  2007cited by this paper
• The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action

  2007cited by this paper
• The Antinociceptive Effects of Local Injections of Propofol in Rats Are Mediated in Part by Cannabinoid CB1 and CB2 Receptors

  2007cited by this paper
• Anandamide Metabolism by Human Liver and Kidney Microsomal Cytochrome P450 Enzymes to Form Hydroxyeicosatetraenoic and Epoxyeicosatrienoic Acid Ethanolamides

  2007cited by this paper
• Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides?

  2006cited by this paper
• Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.

  2006cited by this paper
• Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids.

  2006cited by this paper
• New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis

  2006cited by this paper
• Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain

  2006cited by this paper
• Plant, synthetic, and endogenous cannabinoids in medicine.

  2006cited by this paper
• Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system

  2006influential reference
• Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain

  2006cited by this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006influential reference
• Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

  2006cited by this paper
• AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain

  2006cited by this paper
• Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti‐inflammatory drug, in acute and inflammatory pain

  2006influential reference
• Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.

  2006cited by this paper
• Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice.

  2006cited by this paper
• Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α

  2006cited by this paper
• Cannabinoid pharmacology: the first 66 years

  2006cited by this paper
• Endocannabinoid mechanisms of pain modulation

  2006cited by this paper
• Site‐specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain

  2006cited by this paper
• Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain.

  2006influential reference
• Modulation of Neuropathic and Inflammatory Pain by the Endocannabinoid Transport Inhibitor AM404 [N-(4-Hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]

  2006influential reference
• Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia.

  2006influential reference
• Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling.

  2006cited by this paper
• Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain.

  2005cited by this paper
• Anandamide transport: a critical review.

  2005cited by this paper
• An endocannabinoid mechanism for stress-induced analgesia

  2005influential reference
• The expanding field of cannabimimetic and related lipid mediators

  2005cited by this paper
• Pharmacological actions of cannabinoids.

  2005cited by this paper
• Cannabinoid agonist, CP 55,940, prevents capsaicin-induced sensitization of spinal cord dorsal horn neurons.

  2005cited by this paper
• Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats

  2005cited by this paper
• Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels.

  2005cited by this paper
• Cannabinoid mechanisms of pain suppression.

  2005influential reference
• Evidence for novel cannabinoid receptors.

  2005cited by this paper
• Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin.

  2005cited by this paper
• The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide

  2005cited by this paper
• Cannabinoid receptor signaling.

  2005cited by this paper
• Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.

  2005influential reference
• Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

  2005cited by this paper
• Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors

  2005influential reference
• CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

  2005cited by this paper

• L-Malic acid from Cissus gongylodes induces cannabinoid-mediated antinociception in mice.

  2026cites this paper
• Endocannabinoids in Saliva: Origins, Significance, and Research Directions.

  2026cites this paper
• How Solving a Dopamine Puzzle Might Resolve the Paradox of Painful Art

  2026cites this paper
• Cannabis-based medicines for chronic neuropathic pain in adults.

  2026cites this paper
• Characterizing Cannabidiol Use in a Breast Cancer Population.

  2025cites this paper
• Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery.

  2025cites this paper
• Alcohol and Cannabis Use for Pain Management: Translational Findings of Relative Risks, Benefits, and Interactions.

  2025cites this paper
• FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders.

  2025cites this paper
• Implications of the mitochondrial CB1 receptor in the brain: from mitochondrial dysfunction to neuroprotection

  2025cites this paper
• Perioperative cannabis use on postoperative pain in immediate alloplastic breast reconstruction.

  2025cites this paper
• Combined Endocannabinoid and Cyclooxygenase Inhibition Additively Attenuates Post-Surgical Pain

  2025cites this paper
• Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer

  2025cites this paper
• Interactions between cannabis use and chronic pain on sleep architecture: Findings from in-home EEG recordings.

  2025cites this paper
• The influence of genetics on the endocannabinoid system gene expression and relevance for targeting reproductive conditions

  2025cites this paper
• The Contribution of Baseline Circulating Endocannabinoids to Individual Differences in Human Pain Sensitivity: A Quantitative Sensory Testing Study

  2025cites this paper
• Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials

  2025cites this paper
• Cannabidiol and multi-modal exercise for chemotherapy-induced peripheral neuropathy in cancer survivors

  2025cites this paper
• Therapeutic potential of cannabidiol in oral disorders: A systematic review of clinical evidence.

  2025cites this paper
• Changes in peripheral endocannabinoid levels in substance use disorders: a review of clinical evidence

  2025cites this paper
• Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis

  2025cites this paper
• Cannabis use in chronic pancreatitis: A narrative review.

  2025cites this paper
• Cannabis sativa Root Extract Exerts Anti-Nociceptive and Anti-Inflammatory Effects via Endocannabinoid Pathway Modulation In Vivo and In Vitro

  2025cites this paper
• Experimental and Pre-Analytical Considerations of Endocannabinoid Quantification in Human Biofluids Prior to Mass Spectrometric Analysis

  2025cites this paper
• Chronic inflammatory pain and chronic THC vapor inhalation alter midbrain neuronal activity.

  2025cites this paper
• Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson’s disease

  2024cites this paper
• Cannabinoid and Serotonergic Systems: Unraveling the Pathogenetic Mechanisms of Stress-Induced Analgesia

  2024cites this paper
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

  2024cites this paper
• Use of cannabinoids for acute postoperative pain.

  2024cites this paper
• Structure-based identification of a G protein–biased allosteric modulator of cannabinoid receptor CB1

  2024cites this paper
• Effects of Acupuncture on Cartilage Degradation and Joint Pain in Osteoarthritis

  2024cites this paper
• Ocular effects of synthetic cannabinoids: a case-control study

  2024cites this paper
• Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders

  2024cites this paper
• The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: in vitro study on neurite outgrowth

  2024cites this paper
• Clinical measures in chronic neuropathic pain are related to the Kennedy and endocannabinoid pathways

  2024cites this paper
• Biodegradable cannabidiol: a potential nanotherapeutic for neuropathic pain

  2024cites this paper
• Cannabidiol (CBD): Confronting consumers' expectations of therapeutic benefits with pharmacological reality.

  2024cites this paper
• Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders

  2024cites this paper
• Cannabinoid receptor-2 expression in canine multicentric diffuse large B-cell lymphoma: An immunohistochemical, digital pathology and clinical analysis.

  2024cites this paper
• Dynamic Mechanism for Subtype Selectivity of Endocannabinoids

  2024cites this paper
• The endocannabinoid system as a therapeutic target in neuropathic pain: a review

  2024cites this paper
• Exploring β-caryophyllene: a non-psychotropic cannabinoid's potential in mitigating cognitive impairment induced by sleep deprivation

  2024cites this paper
• Comprehensive endometriosis care: a modern multimodal approach for the treatment of pelvic pain and endometriosis

  2024cites this paper
• Investigating endocannabinoid system and subjective responses to exercise in cancer patients: Rationale and future research directions

  2024cites this paper
• Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson's Disease

  2024cites this paper
• Perspectives on the use of cannabinoids and their benefits in the treatment of chronic pain

  2024cites this paper
• SGIP1 Deletion in Mice Attenuates Mechanical Hypersensitivity Elicited by Inflammation

  2024cites this paper
• Nanocarriers for Cannabinoid Delivery: Enhancing Therapeutic Potential.

  2024cites this paper
• Improved quality of life and pain relief in mature horses with osteoarthritis after oral transmucosal cannabidiol oil administration as part of an analgesic regimen

  2024cites this paper
• Licofelone, a Dual COX/LOX Inhibitor, Ameliorates Paclitaxel-Induced Mechanical Allodynia in Rats in a Cannabinoid Receptor-Dependent Manner

  2024cites this paper
• Anandamide modulation of monocyte-derived Langerhans cells: implications for immune homeostasis and skin inflammation

  2024cites this paper
• THC vapor inhalation attenuates hyperalgesia in rats using a chronic inflammatory pain model.

  2024cites this paper
• JWH-182: a safe and effective synthetic cannabinoid for chemotherapy-induced neuropathic pain in preclinical models

  2024cites this paper
• Evaluation of the effect of cannabidiol on the THLE-2 liver cell line exposed to lead.

  2024cites this paper
• Uso de cannabinoides en el dolor agudo posoperatorio

  2024cites this paper
• The role of cannabinoids in pain modulation in companion animals

  2023cites this paper
• The endocannabinoid systemʼs involvement in motor development relies on cannabinoid receptors, TRP channels, and Sonic Hedgehog signaling

  2023cites this paper
• A single dose of cannabidiol (CBD) positively influences measures of stress in dogs during separation and car travel

  2023cites this paper
• A Systematic Review of MRI Studies and the “Emotional paiN and social Disconnect (END)” Brain Model of Suicidal Behavior in Youth

  2023cites this paper
• Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain.

  2023cites this paper
• Cannabinoids, Endocannabinoids, and Synthetic Cannabimimetic Molecules in Neuromuscular Disorders

  2023cites this paper
• Assessing Dose- and Sex-Dependent Antinociceptive Effects of Cannabidiol and Amitriptyline, Alone and in Combination, and Exploring Mechanism of Action Involving Serotonin 1A Receptors

  2023cites this paper
• Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System

  2023cites this paper
• Cannabis Science and Therapeutics: An Overview for Clinicians

  2023cites this paper
• Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

  2023cites this paper
• Can cannabidiol have an analgesic effect?

  2023cites this paper
• The Place of Cannabinoids in the Treatment of Gynecological Pain

  2023cites this paper
• Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy

  2023cites this paper
• The Endocannabinoid System a Turning Point in Optimizing Physiotherapy Procedures in Knee Osteoarthritis

  2023cites this paper
• Structural basis for activation of CB1 by an endocannabinoid analog

  2023cites this paper
• Electroacupuncture Exerts Analgesic Effects by Restoring Hyperactivity via Cannabinoid Type 1 Receptors in the Anterior Cingulate Cortex in Chronic Inflammatory Pain

  2023cites this paper
• Development of the High-Affinity Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [18F]LUZ5-d8

  2023cites this paper
• Analgesic effects and metabolome analyses of laser- and electro-acupuncture combined therapies in paclitaxel-induced neuropathic pain model

  2023influential citation
• Cetirizine and Levetiracetam as Inhibitors of Monoacylglycerol Lipase: Investigating Their Repurposing Potential as Novel Osteoarthritic Pain Therapies

  2023cites this paper
• Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation

  2023cites this paper
• Chronic THC vapor inhalation rescues hyperalgesia in rats with chronic inflammation and produces sex-specific alterations in midbrain neuronal activity

  2023cites this paper
• Saffron (Crocus sativus) and its constituents for pain management: A review of current evidence

  2023cites this paper
• Understanding the Dynamics of the Structural States of Cannabinoid Receptors and the Role of Different Modulators

  2022cites this paper
• Pharmacokinetics of metamizole (dipyrone) as an add-on in calves undergoing umbilical surgery

  2022cites this paper
• Rapid treatments for depression: Endocannabinoid system as a therapeutic target.

  2022cites this paper
• Inhibiting the endocannabinoid degrading enzymes FAAH and MAGL during zebrafish embryogenesis alters sensorimotor function.

  2022cites this paper
• Clinical Evidence of Cannabinoids in Migraine: A Narrative Review

  2022cites this paper
• Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition

  2022cites this paper
• Lack of Association between (AAT)n Polymorphism of the CNR1 Gene Encoding the Cannabinoid Receptor (CB1) and Patient’s Quality of Life

  2022cites this paper
• Mechanismen der endogenen Schmerzhemmung

  2022cites this paper
• Current Understanding of Phantom Pain and its Treatment.

  2022cites this paper
• Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives

  2022cites this paper
• EXPLORING THE EFFICACY AND SAFETY OF CANNABIS IN THE MANAGEMENT OF FIBROMYALGIA

  2022cites this paper
• Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

  2022cites this paper
• 2‐Arachidonoylglycerol‐mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice

  2022cites this paper
• „exercise induced hypoalgesia“ – Integration von sensomotorischer Beanspruchung und Schmerzhemmung

  2022cites this paper
• Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.

  2022cites this paper
• 2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties

  2022cites this paper
• Developing Oligo Probes for Chromosomes Identification in Hemp (Cannabis sativa L.)

  2022cites this paper
• Metabolic responses in the cortex and hippocampus induced by Il-15rα mutation.

  2022cites this paper
• Pristimerin, a triterpene that inhibits monoacylglycerol lipase activity, prevents the development of paclitaxel-induced allodynia in mice

  2022cites this paper
• Diffuse noxious inhibitory controls and conditioned pain modulation: a shared neurobiology within the descending pain inhibitory system?

  2022cites this paper
• Modulation of cannabinoid receptor signaling by endocannabinoids

  2022cites this paper
• Biological Effects of Cannabidiol on Human Cancer Cells: Systematic Review of the Literature.

  2022cites this paper
• Sex‐specific cannabinoid 1 receptors on GABAergic neurons in the ventrolateral periaqueductal gray mediate analgesia in mice

  2022cites this paper
• Cannabinoids For Fibromyalgia: An Updated Systematic Review

  2022cites this paper